97 related articles for article (PubMed ID: 2801726)
1. Purification and large-scale preparation of antithrombin III.
Hoffman DL
Am J Med; 1989 Sep; 87(3B):23S-26S. PubMed ID: 2801726
[TBL] [Abstract][Full Text] [Related]
2. Characterization and viral safety validation study of a pasteurized therapeutic concentrate of antithrombin III obtained through affinity chromatography.
Biescas H; Gensana M; Fernández J; Ristol P; Massot M; Watson E; Vericat F
Haematologica; 1998 Apr; 83(4):305-11. PubMed ID: 9592979
[TBL] [Abstract][Full Text] [Related]
3. A single-step method for the isolation of antithrombin III.
Wickerhauser M; Williams C
Vox Sang; 1984; 47(6):397-405. PubMed ID: 6516292
[TBL] [Abstract][Full Text] [Related]
4. A highly purified antithrombin III concentrate prepared from human plasma fraction IV-1 by affinity chromatography.
Lebing WR; Hammond DJ; Wydick JE; Baumbach GA
Vox Sang; 1994; 67(2):117-24. PubMed ID: 7801599
[TBL] [Abstract][Full Text] [Related]
5. Phosphotungstate as a useful eluent for antithrombin III purification by heparin-agarose affinity chromatography.
Tajima Y; Shizuka R; Oshitani S; Amagai H
Thromb Res; 1990 Mar; 57(5):697-704. PubMed ID: 2339364
[TBL] [Abstract][Full Text] [Related]
6. Development of large scale fractionation methods. VII. Preparation of antithrombin III concentrate.
Wickerhauser M; Williams C; Mercer J
Vox Sang; 1979; 36(5):281-93. PubMed ID: 462917
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
[TBL] [Abstract][Full Text] [Related]
8. Pasteurisation induced changes in an antithrombin III concentrate.
Winkelman L; Haddon ME
Thromb Res; 1986 Jul; 43(2):219-27. PubMed ID: 3738862
[TBL] [Abstract][Full Text] [Related]
9. AT III Barcelona: a familial quantitative-qualitative AT III deficiency.
Grau E; Fontcuberta J; Félez J; de Diego I; Soto R; Rutllant ML
Thromb Haemost; 1988 Feb; 59(1):13-7. PubMed ID: 3363529
[TBL] [Abstract][Full Text] [Related]
10. Quantitative and qualitative congenital deficiency of antithrombin III: a new molecular variant called ATIII-Barcelona 2.
Fontcuberta J; Grau E; Rubio N; Félez J; Rutllant ML
Thromb Res; 1988 Jul; 51(1):75-81. PubMed ID: 3413737
[TBL] [Abstract][Full Text] [Related]
11. Isolation of plasma proteins from the clotting cascade by heparin affinity chromatography.
Josić D; Bal F; Schwinn H
J Chromatogr; 1993 Feb; 632(1-2):1-10. PubMed ID: 8454710
[TBL] [Abstract][Full Text] [Related]
12. [Studies on antithrombin III. I. Purification and some properties of antithrombin III (ATIII), and the relationship between plasma antithrombin activity and ATIII antigen concentration (author's transl)].
Takahashi K
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):879-88. PubMed ID: 7234301
[No Abstract] [Full Text] [Related]
13. Purification and properties of guinea pig antithrombin III.
Heck L; Rosenberg R; Remold H
Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072
[TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of human antithrombin III synthesized in mammalian cells.
Wasley LC; Atha DH; Bauer KA; Kaufman RJ
J Biol Chem; 1987 Oct; 262(30):14766-72. PubMed ID: 3667601
[TBL] [Abstract][Full Text] [Related]
15. Commercial antithrombin concentrate contains inactive L-forms of antithrombin.
Chang WS; Harper PL
Thromb Haemost; 1997 Feb; 77(2):323-8. PubMed ID: 9157590
[TBL] [Abstract][Full Text] [Related]
16. Manufacturing process of anti-thrombin III concentrate: viral safety validation studies and effect of column re-use on viral clearance.
Morrica A; Nardini C; Falbo A; Bailey AC; Bucci E
Biologicals; 2003 Sep; 31(3):165-73. PubMed ID: 12935804
[TBL] [Abstract][Full Text] [Related]
17. Affinity chromatography in the separation of human alpha 1-antitrypsin (alpha 1-AT) and antithrombin-III (AT-III).
D'Souza S; Ananthakrishnan R
Aust J Exp Biol Med Sci; 1979 Jun; 57(3):245-50. PubMed ID: 316999
[TBL] [Abstract][Full Text] [Related]
18. Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate.
Büller HR; ten Cate JW
Am J Med; 1989 Sep; 87(3B):44S-48S. PubMed ID: 2679070
[TBL] [Abstract][Full Text] [Related]
19. Separation of active and inactive forms of human antithrombin by heparin affinity chromatography.
Heger A; Grunert T; Schulz P; Josic D; Buchacher A
Thromb Res; 2002 Apr; 106(2):157-64. PubMed ID: 12182916
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
